Literature DB >> 17263721

Evaluation of glargine group-start sessions in patients with type 2 diabetes as a strategy to deliver the service.

A A Tahrani1, S Digwood, C Lee, P Moulik.   

Abstract

Improving glycaemic control in patients with type 2 diabetes reduces microvascular complications. The national service framework for diabetes and the new general medical service contract have been aiming to direct more focus on improving HbA1c. These measures have resulted in increasing number of patients being initiated on insulin therapy, which increases the workload of diabetes specialist nurses (DSNs). Initiating insulin on a one-to-one basis is time consuming. As a result DSN-led insulin group-start sessions were introduced. To evaluate DSN-led glargine group-start and self-titration as a strategy of providing service. We assessed the impact of this method on the use of DSNs time, HbA1c and on patients' satisfaction. A prospective audit in a district general hospital. Groups of 5-7 patients received two 2-h sessions at weeks 0 and 2. During these sessions, patients were initiated on insulin glargine and received an educational package and a self-titration protocol. DSNs did not see patients after week 2. Patients were able to phone the DSNs for advice till the end of the titration period. Patients completed Diabetes Treatment Satisfaction Questionnaire (DTSQ) at baseline, week 2 and 12 months. Weight and HbA1c were assessed at base line and 12 months later. Twenty-nine consecutive patients were included. Baseline HbA1c improved at 6 months and remained stable at 12 months (medians 10.0, 8.7 and 8.9 respectively, p < 0.001). DTSQ score improved between week 0 and 2 and this was maintained at 12 months (medians 26, 35 and 34 respectively, p < 0.001). After week 2, the DSNs spent a median of 21 min advising patients by phone during the titration period. Weight did not increase significantly. In our centre, DSN-led insulin group-start sessions and self-titration improved glycaemic control. Patients were satisfied with this method of starting insulin. This was achieved with minimal DSNs time and input and proved to be effective, yet less time consuming.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17263721     DOI: 10.1111/j.1742-1241.2006.01190.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  6 in total

1.  Bolus guide: a novel insulin bolus dosing decision support tool based on selection of carbohydrate ranges.

Authors:  Gali Shapira; Ofer Yodfat; Arava HaCohen; Paul Feigin; Richard Rubin
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

2.  How does treatment satisfaction work?: Modeling determinants of treatment satisfaction and preference.

Authors:  Mark Peyrot; Richard R Rubin
Journal:  Diabetes Care       Date:  2009-05-26       Impact factor: 17.152

3.  Psychometric properties of an instrument for assessing the experience of patients treated with inhaled insulin: the inhaled insulin treatment questionnaire (IITQ).

Authors:  Richard R Rubin; Mark Peyrot
Journal:  Health Qual Life Outcomes       Date:  2010-03-24       Impact factor: 3.186

4.  Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study.

Authors:  Shoko Tsukube; Yukio Ikeda; Takashi Kadowaki; Masato Odawara
Journal:  Diabetes Ther       Date:  2015-06-04       Impact factor: 2.945

5.  Development and validation of the Diabetes Medication System Rating Questionnaire-Short Form.

Authors:  M Peyrot; Y Xu; R R Rubin
Journal:  Diabet Med       Date:  2014-04-18       Impact factor: 4.359

6.  Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily.

Authors:  J H Best; K S Boye; R R Rubin; D Cao; T H Kim; M Peyrot
Journal:  Diabet Med       Date:  2009-07       Impact factor: 4.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.